When is the MPEP 2412.05(c) guidance on sequence variants applicable?

The guidance provided in MPEP 2412.05(c) is applicable under specific conditions: “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” This means that the requirements for representing sequence variants in the “Sequence Listing XML”…

Read More

When does MPEP 2412.03(e) apply to patent applications?

The applicability of MPEP 2412.03(e) is clearly stated in the section: “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” This means that the definition and requirements for “Modified Nucleotide” apply to patent applications…

Read More